The Sabnis laboratory is investigating selective vulnerabilities in the way cancer cells choose to build, fold, and destroy their constituent proteins.  We use patient-derived cell line and xenograft models to test the hypothesis that pediatric sarcomas - a deadly group of connective tissue cancers affecting children and young adults - are "primed" for drugs that disable protein homeostasis pathways.

We are currently hiring motivated and skilled scientists and scientists-in-training at the following levels:

Post-doctoral Fellows (MD or DO trained)

Post-doctoral Fellows (PhD trained)

If interested, please provide a CV and two references to Dr. Sabnis through our contact page.